Feed Category: Mental Health Index

What the latest polls say about 3 key ‘blue wall’ statesMichigan, Pennsylvania and Wisconsin were Democratic strongholds for decades until Donald Trump flipped them in…

Dive Brief: Sage Therapeutics and Biogen will focus on ramping up sales of their Zurzuvae medicine for postpartum depression, giving up on attempts to win…

4 takeaways from Kamala Harris’s ‘closing argument’ at the Ellipse in D.C.Harris was in the same spot where on Jan. 6, 2021, Donald Trump exhorted…

Sage Therapeutics, Inc. (SAGE) came out with a quarterly loss of $1.53 per share versus the Zacks Consensus Estimate of a loss of $1.52. This…

Achieved $11 million in ZURZUVAE® (zuranolone) collaboration revenue during the third quarter of 2024 (50% of the net revenue recorded by Biogen), representing 49% growth…

3Q 2024 Total revenue grew 23% year-over-year, driven by 45% year-over-year growth in Payor revenue Increased 3Q 2024 GAAP Net income to $1.9 million from $4.4 million…

BURLINGTON, Mass. and JERUSALEM, Oct. 29, 2024 (GLOBE NEWSWIRE) — BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced…

BURLINGTON, Mass. and JERUSALEM, Oct. 29, 2024 (GLOBE NEWSWIRE) — BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced…

Neurocrine Biosciences (NBIX) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended September 2024….

MIAMI, Oct. 23, 2024 (GLOBE NEWSWIRE) — NRx Pharmaceuticals, Inc. (Nasdaq: NRXP), a clinical-stage biopharmaceutical company, (“NRx,” the “Company”) and HOPE Therapeutics, Inc., a medical…